Being told you need your aortic valve replaced is unsettling, and the next question is often the hardest: should it be done through a catheter (TAVR) or through open-heart surgery (SAVR)? Both are excellent procedures with decades of evidence behind them. The right choice depends less on which is "newer" and more on your specific anatomy, age, and overall health. This guide explains how the decision is actually made.
What TAVR and SAVR Actually Are
SAVR (surgical aortic valve replacement) is the traditional operation. A cardiac surgeon opens the chest, the heart is temporarily stopped on a heart-lung machine, the diseased valve is removed, and a new mechanical or tissue valve is sewn in place. It has been performed for more than fifty years and remains the gold standard against which everything else is measured.
TAVR (transcatheter aortic valve replacement) is newer and far less invasive. A collapsible valve is threaded up through an artery, usually in the groin, and expanded inside your old valve while your heart keeps beating. There is no large chest incision and no heart-lung machine. Many patients go home within a day or two.
Neither is universally "better." The honest answer is that the best option is the one matched to your individual situation, and that match is what a careful second opinion is designed to find.
How Age and Surgical Risk Drive the Decision
For years, TAVR was reserved for patients considered too high-risk for surgery. That has changed dramatically. Large clinical trials now show TAVR performing as well as or better than SAVR across high, intermediate, and even low surgical risk groups for many patients. As a result, age and frailty have become central to the conversation.
Older patients
If you are in your seventies or older, TAVR is frequently favored. Recovery is faster, the procedure avoids the stress of open surgery, and valve durability matters less when measured against natural life expectancy. Many guidelines lean toward TAVR for patients over 75 with suitable anatomy.
Younger patients
If you are younger, the calculation shifts. A surgical valve, particularly a mechanical one, can last decades, and surgery gives the team the chance to address other problems at the same time. Long-term durability and the question of future re-intervention become more important when you have many years ahead of you.
This is why one of the most useful first steps is understanding your own numbers. A structured risk calculator can give you a sense of your surgical risk before any conversation about which valve to choose.
Anatomy Matters More Than You Might Think
Even when age and risk point one direction, your anatomy can point another. TAVR depends on having the right size and shape of valve and arteries to deliver the device safely. Several anatomical factors influence eligibility:
- Valve type: A bicuspid aortic valve (two leaflets instead of three) can make TAVR more technically challenging, and surgery is sometimes preferred.
- Annulus size: The valve opening must fall within the range available for transcatheter devices.
- Coronary arteries: If the openings of your coronary arteries sit very close to the valve, a transcatheter valve could obstruct them.
- Access vessels: The arteries in your groin and chest must be wide enough and healthy enough to pass the device.
- Other heart disease: If you also need bypass surgery or repair of another valve, a single open operation may make more sense than separate procedures.
These details come from your CT scan and echocardiogram. A second look at those images by an experienced eye sometimes changes the recommendation entirely.
Durability, Re-Intervention, and the Long View
One of the most important and least discussed topics is what happens years down the road. Tissue valves, whether placed surgically or by catheter, eventually wear out. A reassuring development is that a worn-out surgical valve can often be treated later with a TAVR procedure (called valve-in-valve), and a worn-out TAVR valve can sometimes be treated with another TAVR. Planning that lifetime strategy in advance, rather than one procedure at a time, is the mark of a thoughtful Heart Team.
Mechanical valves, by contrast, do not wear out the way tissue valves do, but they require lifelong blood-thinning medication and careful monitoring. That trade-off, freedom from future surgery versus daily medication and bleeding risk, is deeply personal and deserves a real discussion.
What Recovery Looks Like With Each Option
For many patients, the practical difference between the two procedures shows up most clearly in recovery. After TAVR, the hospital stay is often just one or two days, and because there is no chest incision or breastbone to heal, many people return to ordinary activities within a couple of weeks. The main access site, usually in the groin, requires some care but heals quickly.
SAVR involves a longer arc. A hospital stay of four to six days is typical, and because the breastbone is divided during the operation, it takes roughly eight to twelve weeks to knit back together. During that time there are lifting restrictions and a more gradual return to driving and work. The trade-off is that open surgery allows the team to do more in a single operation, including addressing additional valves or coronary blockages at the same time.
Neither recovery is inherently better; they suit different lives and different priorities. A retired patient who wants the gentlest possible procedure and a working parent who needs durability for decades may reasonably reach different conclusions even with similar valves.
Questions Worth Asking Before You Decide
Whichever direction your team leans, a few questions tend to sharpen the conversation and surface anything that has been glossed over:
- Is my anatomy genuinely suitable for both options, or only one?
- What is my surgical risk score, and how does it factor into the recommendation?
- What is the lifetime plan if this valve eventually wears out?
- How many of each procedure does this center perform per year?
- Do I have any other heart problems that should be fixed at the same time?
The answers should feel specific to you. If they sound generic, that is a reasonable signal to seek another perspective. You can read more about how aortic valve disease is evaluated in our learn library.
It also helps to know that a recommendation is not always final. Anatomy can be borderline, imaging can be read more than one way, and the field continues to evolve as longer-term data on transcatheter valves accumulates. If you have been told you are eligible for only one option, it is entirely reasonable to ask why, and to have a second physician confirm whether the other option was truly ruled out or simply not the local team's preference. That distinction matters, because preference and possibility are not the same thing.
Why a Dual-Physician Second Opinion Helps
The TAVR-versus-SAVR decision sits at the intersection of surgery and cardiology, which is exactly why it benefits from both perspectives. At WhiteGloveMD, your records are reviewed by a Heart Team pairing a cardiac surgeon with a cardiologist, so you receive a balanced recommendation rather than one shaped by a single specialty's bias. We look at your imaging, your risk profile, and your goals, and we explain the reasoning in plain language.
If you want to understand more about how a structured review works, our how it works page walks through the process step by step.
You should not have to make a permanent decision about your heart with lingering doubts. A WhiteGloveMD cardiac second opinion gives you a clear, written recommendation from a dual-physician Heart Team, with a 24-hour review after we receive your records and pricing from $500. Request a call to talk through your aortic valve options with someone who will take the time to explain them.